Finally, plasma MPs were analyzed in 72 ET patients by Charpentier et al. Specifically, authors found that ET patients harboring JAK2-V617F mutation, at diagnosis, showed more circulating platelet derived-MPs and a higher MP-associated procoagulant activity than CALR-mutated and triple-negative ET patients. The gene discussed is JAK2; the disease is essential thrombocythemia.